Hyderabad pharma firm executives donate ₹2 crore to TTD scheme in Tirumala

Biophore India Pharmaceuticals chief executive officer Jagadish and chief strategy officer Manik Reddy Pullagurla each contributed ₹1 crore; TTD chairman B.R. Naidu received the demand drafts at his Tirumala Camp Office.

Hyderabad: Hyderabad-based Biophore India Pharmaceuticals Private Limited chief executive officer Jagadish and chief strategy officer Manik Reddy Pullagurla donated ₹2 crore to TTD’s Sri Balaji Arogya Varaprasadini Scheme, each contributing ₹1 crore.

The demand drafts were handed over to TTD chairman B.R. Naidu at his Camp Office in Tirumala. TTD board member A. Rangasri was also present.

Annaprasadam Trust receives ₹60.61 lakh

The Sri Venkateswara Annaprasadam Trust received donations totalling ₹60.61 lakh. SSNR Projects Private Limited, Visakhapatnam, gave ₹10.50 lakh; devotee Viswa C.V. Cherukuri, Vanta Infracon Private Limited, Vertex County LLP and Sai Leela Electrical Projects Private Limited, Hyderabad, contributed ₹10 lakh each; and Jonnalagadda Kiran Kumar of Thullur, Amaravati, donated ₹10,11,116.

Hyderabad-based Biophore India Pharmaceuticals Private Limited chief executive officer Jagadish and chief strategy officer Manik Reddy Pullagurla donated ₹2 crore to TTD’s Sri Balaji Arogya Varaprasadini Scheme, each contributing ₹1 crore.

The demand drafts were handed over to TTD chairman B.R. Naidu at his Camp Office in Tirumala. TTD board member A. Rangasri was also present.

Reliance to donate Tirumala 25 electric buses worth ₹27.5 crore; Anant Ambani donates hair

Annaprasadam Trust receives ₹60.61 lakh

The Sri Venkateswara Annaprasadam Trust received donations totalling ₹60.61 lakh on Tuesday. SSNR Projects Private Limited, Visakhapatnam, gave ₹10.50 lakh; devotee Viswa C.V. Cherukuri, Vanta Infracon Private Limited, Vertex County LLP and Sai Leela Electrical Projects Private Limited, Hyderabad, contributed ₹10 lakh each; and Jonnalagadda Kiran Kumar of Thullur, Amaravati, donated ₹10,11,116.

Hyderabad devotee donates ₹1 crore to TTD Trusts

TTD board member Nannapaneni Sadasiva Rao handed over the drafts to Mr. B.R. Naidu at the Chairman’s Camp Office in Tirumala on behalf of the donors. TTD board members Panabaka Lakshmi and Jasti Poorna Sambasiva Rao and SAAP chairman Ravi Naidu were also present.

Guntur, Bengaluru, Visakhapatnam donors

Brinda Neuro Centre of Guntur donated ₹10,00,116 each to the Sri Venkateswara Annaprasadam Trust, the Sri Venkateswara Pranadana Trust and the SV BIRRD Trust on Tuesday. Hanuma Srinivasa Reddy and Siddhartha presented the drafts to TTD executive officer Muddada Ravichandra at the Ranganayakula Mandapam in the Sri Venkateswara Temple.

Sripathi Srinivas and Kotaru Sunil of Bengaluru donated ₹10,00,116 to the Sri Venkateswara Annaprasadam Trust, and Chagarlamudi Seetharamaiah of Visakhapatnam donated ₹10,00,116 to the SV BIRRD Trust. TTD board member Nannapaneni Sadasiva Rao handed over their drafts to Mr. Muddada Ravichandra at the same venue.

Source: The Hindu

Related Posts

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

The Team Meticulously averted the Risk of Thrombosis, Husband was Donor Delhi/NCR : Doctors at Yashoda Medicity have successfully performed a high-risk kidney transplant in a 28-year-old woman with Antiphospholipid…

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta, a UK-based clinical stage biotech, is differentiated clinical-stage oncology specialist, increasingly defined by continuing progress with its second-generation pre|CISION tumour-activated Peptide Drug Conjugate (PDC) platform. The lead Gen Two…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Puresta launches EVERQ, AI-powered skin-health platform

Puresta launches EVERQ, AI-powered skin-health platform

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell therapy for autism only in approved clinical trials: Centre